Altered expression of hyaluronan, HAS1-2, and HYAL1-2 in oral lichen planus

Journal of Oral Pathology and Medicine

Volumn 44, Issue 6, 2015, Pages 401-409

  Siponen, Maria ^a,b   Kullaa, Arja ^a,c   Nieminen, Pentti ^d   Salo, Tuula ^a,e,f,g   Pasonen Seppänen, Sanna ^h  

^a UNIVERSITY OF OULU   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Oulu Health Center   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g UNIVERSITY OF CAMPINAS   (Brazil)

^h UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

HAS; HYAL; CD44; Hyaluronan; Oral lichen planus; Tacrolimus

Indexed keywords

CD44V ANTIGEN; GLYCOSAMINOGLYCAN; HYALURONAN SYNTHASE 1; HYALURONAN SYNTHASE 2; HYALURONIC ACID; HYALURONIDASE; HYALURONIDASE 1; HYALURONIDASE 2; TACROLIMUS; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; CELL ADHESION MOLECULE; GLUCURONOSYLTRANSFERASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HAS1 PROTEIN, HUMAN; HAS2 PROTEIN, HUMAN; HAS3 PROTEIN, HUMAN; HERMES ANTIGEN; HYAL2 PROTEIN, HUMAN; HYALURONAN SYNTHASE; HYALURONOGLUCOSAMINIDASE;

ADULT; ARTICLE; BASEMENT MEMBRANE; BIOTECHNOLOGY; CELL MEMBRANE; CELL SURFACE; ENDOTHELIUM CELL; EPITHELIUM; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MUCOSAL DISEASE; ORAL LICHEN PLANUS; PRIORITY JOURNAL; PROBABILITY; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; INFLAMMATION; METABOLISM; MOUTH MUCOSA; PATHOLOGY;

ANTIGENS, CD44; CELL ADHESION MOLECULES; CHI-SQUARE DISTRIBUTION; GLUCURONOSYLTRANSFERASE; GPI-LINKED PROTEINS; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LICHEN PLANUS, ORAL; MOUTH MUCOSA;

EID: 84947730020     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12294     Document Type: Article

References (51)

1. McCartan BE, Healy CM. The reported prevalence of oral lichen planus: a review and critique. J Oral Pathol Med 2008; 37: 447-53.
2. Payeras MR, Cherubini K, Figueiredo MA, Salum FG. Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol 2013; 58: 1057-69.
3. Tammi R, Ripellino JA, Margolis RU, Tammi M. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J Invest Dermatol 1988; 90: 412-4.
4. Tammi R, Pasonen-Seppänen S, Kolehmainen E, Tammi M. Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury. J Invest Dermatol 2005; 124: 898-905.
5. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev 2011; 91: 221-64. (Review)
6. Jokela TA, Kuokkanen J, Kärnä R, et al. Mannose reduces hyaluronan and leukocytes in wound granulation tissue and inhibits migration and hyaluronan-dependent monocyte binding. Wound Repair Regen 2013; 21: 247-55.
7. Tammi RH, Kultti A, Kosma VM, Pirinen R, Auvinen R, Tammi MI. Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin Cancer Biol 2008; 18: 288-95. (Review)
8. Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma VM. Hyaluronan in human malignancies. Exp Cell Res 2011; 317: 383-91. (Review)
9. Siiskonen H, Törrönen K, Kumlin T, Rilla K, Tammi MI, Tammi RH. Chronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis. J Histochem Cytochem 2011; 59: 908-17.
10. Siiskonen H, Poukka M, Tyynelä-Korhonen K, Sironen R, Pasonen-Seppänen S. Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma. BMC Cancer 2013; 13: 181.
11. Kosunen A, Ropponen K, Kellokoski J, et al. Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma. Oral Oncol 2004; 40: 257-63.
12. Weigel PH, DeAngelis PL. Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem 2007; 282: 36777-81. (Review).
13. Heldin P, Karousou E, Bernert B, Porsch H, Nishitsuka K, Skandalis SS. Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis. Connect Tissue Res 2008; 49: 215-8.
14. Pasonen-Seppänen S, Hyttinen JMT, Rilla K, et al. Role of CD44 in the organization of keratinocyte pericellular hyaluronan. Histochem Cell Biol 2012; 137: 107-20.
15. Puré E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001; 7: 213-21.
16. Chaiyarit P, Thongprasom K, Satayut S, et al. Alteration of the expression of CD44 isoforms in oral epithelia and saliva from patients with oral lichen planus. J Clin Immunol 2008; 28: 26-34.
17. Tammi R, Rilla K, Pienimäki JP, et al. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem 2001; 276: 35111-22.
18. Kosunen A, Pirinen R, Ropponen K, et al. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. Oral Oncol 2007; 43: 51-9.
19. Neppelberg E, Loro LL, Oijordsbakken G, Johannessen AC. Altered CD40 and E-cadherin expression-putative role in oral lichen planus. J Oral Pathol Med 2007; 36: 153-60.
20. Girish KS, Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci 2007; 80: 1921-43. (Review)
21. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 2004; 83: 317-25. (Review).
22. Harada H, Takahashi M. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem 2007; 282: 5597-607.
23. Puissant E, Gilis F, Dogné S, Flamion B, Jadot M, Boonen M. Subcellular trafficking and activity of Hyal-1 and its processed forms in murine macrophages. Traffic 2014; 15: 500-15.
24. Andre B, Duterme C, van Moer K, Mertens-Strijthagen J, Jadot M, Flamion B. Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raft-associated hyaluronidase. Biochem Biophys Res Commun 2011; 411: 175-9.
25. Al-Johani KA, Hegarty AM, Porter SR, Fedele S. Calcineurin inhibitors in oral medicine. J Am Acad Dermatol 2009; 61: 829-40. (Review)
26. López-Jornet P, Camacho-Alonso F, Salazar-Sanchez N. Topical tacrolimus and pimecrolimus in the treatment of oral lichen planus: an update. J Oral Pathol Med 2010; 39: 201-5.
27. Lodi G, Carrozzo M, Furness S, Thongprasom K. Interventions for treating oral lichen planus: a systematic review. Br J Dermatol 2012; 166: 938-47.
28. Tammi R, Ågren UM, Tuhkanen AL, Tammi M. Hyaluronan metabolism in skin. Prog Histochem Cytochem 1994; 29: 1-81. (Review).
29. Tammi R, Tammi M, Häkkinen L, Larjava H. Histochemical localization of hyaluronate in human oral epithelium using a specific hyaluronate-binding probe. Arch Oral Biol 1990; 35: 219-24.
30. Hämäläinen K, Kosma V-M, Eloranta M-L, et al. Downregulated CD44 and hyaluronan expression in vulvar intraepithelial neoplasia and squamous cell carcinomas. Acta Obstet Gynecol Scand 2010; 89: 108-19.
31. Rilla K, Siiskonen H, Spicer AP, Hyttinen JM, Tammi MI, Tammi RH. Plasma membrane residence of hyaluronan synthase is coupled to its enzymatic activity. J Biol Chem 2005; 280: 31890-7.
32. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002; 21: 25-9. (Review)
33. Campo GM, Avenoso A, Campo S, D'Ascola A, Nastasi G, Calatroni A. Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie 2010; 92: 204-15.
34. Bollyky PI, Falk BA, Wu RP, Buckner JH, Wight TN, Nepom GT. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J Leukoc Biol 2009; 86: 567-72.
35. Termeer CC, Hennies J, Voith U, et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000; 165: 1863-70.
36. Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195: 99-111.
37. Janardhanam SB, Prakasam S, Swaminathan VT, Kodumudi KN, Zunt SL, Srinivasan M. Differential expression of TLR-2 and TLR-4 in the epithelial cells in oral lichen planus. Arch Oral Biol 2012; 57: 495-502.
38. Siponen M, Kauppila JH, Soini Y, Salo T. TLR4 and TLR9 are induced in oral lichen planus. J Oral Pathol Med 2012; 41: 741-7.
39. Harris AJ, Dean D, Burge S, Wojnarowska F. Changes in CD44 isoform expression during inflammatory skin disease. Clin Exp Dermatol 1997; 22: 128-33.
40. Orteu CH, Li W, Allen MH, Smith NP, Barker JN, Whittaker SJ. CD44 variant expression in cutaneous T-cell lymphoma. J Cutan Pathol 1997; 24: 342-9.
41. Herold-Mende C, Seiter S, Born AI, et al. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 1996; 179: 66-73.
42. Törrönen K, Nikunen K, Kärnä R, Tammi M, Tammi R, Rilla K. Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes. Histochem Cell Biol 2014; 141: 17-31.
43. Yamada Y, Itano N, Hata K, Ueda M, Kimata K. Differential regulation by IL-1beta and EGF of expression of three different hyaluronan synthases in oral mucosal epithelial cells and fibroblasts and dermal fibroblasts: quantitative analysis using real-time RT-PCR. J Invest Dermatol 2004; 122: 631-9.
44. Felszeghy S, Mészár Z, Prehm P, Módis L. The expression pattern of hyaluronan synthase during human tooth development. Arch Oral Biol 2005; 50: 175-9.
45. Ohno S, Ijuin C, Doi T, Yoneno K, Tanne K. Expression and activity of hyaluronidase in human periodontal ligament fibroblasts. J Periodontol 2002; 73: 1331-7.
46. Shimabukuro Y, Ichikawa T, Takayama S, et al. Fibroblast growth factor-2 regulates the synthesis of hyaluronan by human periodontal ligament cells. J Cell Physiol 2005; 203: 557-63.
47. Stern R. Hyaluronidases in cancer biology. Semin Cancer Biol 2008; 18: 275-80. (Review)
48. Lokeshwar VB, Selzer MG. Hyaluronidase: both a tumor promoter and suppressor. Semin Cancer Biol 2008; 18: 281-7. (Review)
49. Gomez CS, Gomez P, Knapp J, Jorda M, Soloway MS, Lokeshwar VB. Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence. J Urol 2009; 182: 1350-6.
50. Tan JX, Wang XY, Li HY, et al. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer. Int J Cancer 2011; 128: 1303-15.
51. Kramer MW, Escudero DO, Lokeshwar SD, et al. Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis. Cancer 2011; 117: 1197-209.